Neoadjuvant chemotherapy with cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the head and neck: a randomized Phase III study-Reference-Cited by-同舟云学术

Neoadjuvant chemotherapy with cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the head and neck: a randomized Phase III study

Published:1997-04 Issue:1 Volume:43 Page:23-28
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Lewin Freddi,Damber Lena,Jonsson Håkan,Andersson Torsten,Berthelsen Anne,Biörklund Anders,Blomqvist Erik,Evensen Jan F.,Hansen Hanne S.,Hansen Olfred,Jetlund Olav,Mercke Claes,Modig Hans,Overgaard Marie,Rosengren Bengt,Tausjö Johan,Ringborg Ulrik

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference18 articles.

1. Adjuvant chemotherapy with cis-diamminodichloroplatinum II and 120 hours infusion 5-fluorouracil in stage II and IV squamous cell carcinoma of the head and neck;Decker;Cancer,1983

2. Adjuvant chemotherapy for advanced head and neck squamous carcinoma. Final report of the Head and Neck Contracts Program;Head Neck Contracts Program;Cancer,1987

3. Head and neck squamous cancers;Jacobs,1990

4. Chemotherapy in locally advanced head and neck cancer: a critical reappraisal;Jassem;Cancer Treat. Rev.,1995

5. The Statistical Analysis of Failure Time Data;Kalbfleisch,1980

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy;Cochrane Database of Systematic Reviews;2021-12-20

2. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group;Radiotherapy and Oncology;2021-03

3. Response assessment after induction chemotherapy for head and neck squamous cell carcinoma: From physical examination to modern imaging techniques and beyond;Head & Neck;2017-08-17

4. A network meta-analysis of the sequencing and types of systemic therapies with definitive radiotherapy in locally advanced squamous cell carcinoma of the head and neck (LASCCHN)☆;Oral Oncology;2017-08

5. To review the role and issue of pharmacotherapy for head and neck cancer clarified from previous clinical trials;Toukeibu Gan;2017